[{"path":"https://billdenney.github.io/PKdata/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"William Denney. Author, maintainer. Tim Cacek. Data contributor.            Thanks Tim Cacek ContractKinetica providing anonymized datasets. Sibo Jiang. Data contributor.            Thanks contributing simulated PK data. Chanida Karnpracha. Data contributor. Kaori Ito. Data contributor.","code":""},{"path":"https://billdenney.github.io/PKdata/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Denney W (2023). PKdata: Pharmacokinetic Data Sets. https://github.com/billdenney/PKdata, https://billdenney.github.io/PKdata/.","code":"@Manual{,   title = {PKdata: Pharmacokinetic Data Sets},   author = {William Denney},   year = {2023},   note = {https://github.com/billdenney/PKdata, https://billdenney.github.io/PKdata/}, }"},{"path":"https://billdenney.github.io/PKdata/index.html","id":"pkdata","dir":"","previous_headings":"","what":"Pharmacokinetic Data Sets","title":"Pharmacokinetic Data Sets","text":"Pharmacokinetic data testing software real statically simulated data. target package cover different relevant types data multiple examples type data. Current examples include: Hydrocortisone simulated data sets illustrating oral dosing. CP1805 data illustrating multiple routes dosing compound. TC20160506 (real drug name) real data illustrating multiple doses occurring quick succession. KI20160914 (real drug name) adjusted data illustrating single dosing. Lipoic acid single-dose real data concentration time NCA parameters calculated Kinetica WinNonlin. Xanthohumol metabolite isoxanthohumol single-dose real data complex increases decreases concentration time NCA parameters calculated Kinetica WinNonlin.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/CP1805.html","id":null,"dir":"Reference","previous_headings":"","what":"Pharmacokinetics of CP1805 — CP1805","title":"Pharmacokinetics of CP1805 — CP1805","text":"Pharmacokinetics CP1805","code":""},{"path":"https://billdenney.github.io/PKdata/reference/CP1805.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Pharmacokinetics of CP1805 — CP1805","text":"","code":"CP1805_conc  CP1805_dose  CP1805_demog"},{"path":"https://billdenney.github.io/PKdata/reference/CP1805.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Pharmacokinetics of CP1805 — CP1805","text":"CP1805_conc de-identified data set concentration-time   data CP1805 data frame following variables: ID Subject identifier DAY Day measurement TIME_AFTER_DOSE Time since dose current DAY (hours) TIME Time since first dose DAY 1 (hours) TIMEU Units time, \"hours\" CONC Plasma concentration CP1805 (ug/mL) CONCU Units plasma concentration CP1805, \"ug/mL\" CP1805_dose de-identified data set dosing data   CP1805 data frame following variables: ID Subject identifier ROUTE Route administration DAY Day measurement TIME_AFTER_DOSE Time since dose current DAY (hours) TIME Time since first dose DAY 1 (hours) TIMEU Units time, \"hours\" DOSE Total dose CP1805 (mg) DOSEU Total dose CP1805, \"mg\" NDOSE Dose CP1805 normalized body weight (mg/kg) NDOSEU Units dose CP1805 normalized body weight, \"mg/kg\" CP1805_demog de-identified data set demographic data   CP1805 pharmacokinetics data frame following variables: ID Subject identifier SEX Subject's sex (Male/Female) WEIGHT Subject's body weight (kg) WEIGHTU Units subject's body weight, \"kg\" object class data.frame 320 rows 7 columns. object class data.frame 320 rows 10 columns. object class data.frame 20 rows 4 columns.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/Holder_1999.html","id":null,"dir":"Reference","previous_headings":"","what":"Pharmacokinetics of an experimental compound reported in Table 4 of Holder\n1999 — Holder_1999","title":"Pharmacokinetics of an experimental compound reported in Table 4 of Holder\n1999 — Holder_1999","text":"Observed data set concentration-time data experimental compound. data use sparse PK sampling \"batch\" design animal one sample full profile.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/Holder_1999.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Pharmacokinetics of an experimental compound reported in Table 4 of Holder\n1999 — Holder_1999","text":"","code":"Holder_1999_conc  Holder_1999_dose  Holder_1999_demog"},{"path":"https://billdenney.github.io/PKdata/reference/Holder_1999.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Pharmacokinetics of an experimental compound reported in Table 4 of Holder\n1999 — Holder_1999","text":"Holder_1999_conc data frame describing concentration time following variables: ID Subject identifier TIME Time (hours) TIMEU Units time, \"hr\" CONC Plasma concentration experimental compound (ug/mL) CONCU Units plasma concentration, \"ug/mL\" Holder_1999_dose data frame describing dosing following variables: ID Subject identifier DOSE Dose (mg/kg) DOSEU Units nominal dose, \"mg/kg\" TIME Time start dose (minutes) TIMEU Units time, \"minutes\" ROUTE Route administration, \"intravenous bolus\" Holder_1999_demog data frame describing demographics following variables: ID Subject identifier SEX Animal sex (always \"Female\") SPECIES Species animal (always \"rat\") GROUP Arbitrary group number animal within dose level object class data.frame 108 rows 5 columns. object class data.frame 54 rows 6 columns. object class data.frame 54 rows 4 columns.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/Holder_1999.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Pharmacokinetics of an experimental compound reported in Table 4 of Holder\n1999 — Holder_1999","text":"Holder DJ, Hsuan F, Dixit R, Soper K. method estimating testing area curve serial sacrifice, batch, complete data designs. J Biopharm Stat. 1999;9(3):451-464. doi:10.1081/BIP-100101187","code":""},{"path":"https://billdenney.github.io/PKdata/reference/KI20160914.html","id":null,"dir":"Reference","previous_headings":"","what":"Pharmacokinetics of KI20160914 (Note that KI20160914 is a de-identified name for the drug.) — KI20160914","title":"Pharmacokinetics of KI20160914 (Note that KI20160914 is a de-identified name for the drug.) — KI20160914","text":"Pharmacokinetics KI20160914 (Note KI20160914 de-identified name drug.)","code":""},{"path":"https://billdenney.github.io/PKdata/reference/KI20160914.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Pharmacokinetics of KI20160914 (Note that KI20160914 is a de-identified name for the drug.) — KI20160914","text":"","code":"KI20160914_conc  KI20160914_dose  KI20160914_demog"},{"path":"https://billdenney.github.io/PKdata/reference/KI20160914.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Pharmacokinetics of KI20160914 (Note that KI20160914 is a de-identified name for the drug.) — KI20160914","text":"KI20160914_conc concentration-time data KI20160914.   data.frame following variables: ID Subject identifier PERIOD Period number different visits study TIME Nominal time since first dose DAY 1 current PERIOD (hours) TIME.FIRST.DOSE Nominal time since first dose PERIOD 1 (hours) DAY Study day (since beginning PERIOD 1 CONC Plasma concentration KI20160914 FORMULATION Formulation number KI20160914_dose dosing data.  data.frame   following variables: ID Subject identifier PERIOD Period number different visits study TIME Nominal time since first dose DAY 1 current PERIOD (hours) TIME_FIRST_DOSE Nominal time since first dose PERIOD 1 (hours) TIMEU Units time, \"hours\" DAY Study day (since beginning PERIOD 1 DOSE Dose KI20160914 (mg). FORMULATION Formulation number ROUTE Route administration KI20160914_demog demographic data KI20160914   pharmacokinetics.  data.frame following variables: ID Subject identifier AGE Subject's age (years) SEX Subject's sex (Male/Female) WEIGHT Subject's body weight (kg) object class data.frame 4904 rows 7 columns. object class data.frame 317 rows 9 columns. object class data.frame 159 rows 6 columns.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/Nedelman_1995.html","id":null,"dir":"Reference","previous_headings":"","what":"Pharmacokinetics of an CPI 975 (an experimental drug) reported in Table II of\nNedelman 1995 — Nedelman_1995","title":"Pharmacokinetics of an CPI 975 (an experimental drug) reported in Table II of\nNedelman 1995 — Nedelman_1995","text":"Observed data set concentration-time data experimental compound. data use sparse PK sampling \"batch\" design animal one sample full profile.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/Nedelman_1995.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Pharmacokinetics of an CPI 975 (an experimental drug) reported in Table II of\nNedelman 1995 — Nedelman_1995","text":"","code":"Nedelman_1995_conc  Nedelman_1995_dose  Nedelman_1995_demog"},{"path":"https://billdenney.github.io/PKdata/reference/Nedelman_1995.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Pharmacokinetics of an CPI 975 (an experimental drug) reported in Table II of\nNedelman 1995 — Nedelman_1995","text":"Nedelman_1995_conc data frame describing concentration time following variables: ID Subject identifier TIME Time (hours) TIMEU Units time, \"hr\" CONC Plasma concentration experimental compound (ug/mL) CONCU Units plasma concentration, \"ug/mL\" Nedelman_1995_dose data frame describing dosing following variables: ID Subject identifier DOSE Dose (mg/kg) DOSEU Units nominal dose, \"mg/kg\" TIME Time dose (hours, always 0) TIMEU Units time, \"hr\" ROUTE Route administration, \"oral\" Nedelman_1995_demog data frame describing demographics following variables: ID Subject identifier SEX Animal sex SPECIES Species animal (always \"rat\") object class data.frame 60 rows 5 columns. object class data.frame 60 rows 6 columns. object class data.frame 60 rows 3 columns.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/Nedelman_1995.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Pharmacokinetics of an CPI 975 (an experimental drug) reported in Table II of\nNedelman 1995 — Nedelman_1995","text":"Nedelman JR, Gibiansky E, Lau DT. Applying Bailer’s method AUC confidence intervals sparse sampling. Pharm Res. 1995;12(1):124-128. doi:10.1023/:1016255124336","code":""},{"path":"https://billdenney.github.io/PKdata/reference/TC20160506.html","id":null,"dir":"Reference","previous_headings":"","what":"Pharmacokinetics of TC20160506 (Note that TC20160506 is a de-identified name for the drug.) — TC20160506","title":"Pharmacokinetics of TC20160506 (Note that TC20160506 is a de-identified name for the drug.) — TC20160506","text":"De-identified data set concentration-time data TC20160506. working dataset, aware ANALYTE named \"Parent\" can converted \"Metabolite\".","code":""},{"path":"https://billdenney.github.io/PKdata/reference/TC20160506.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Pharmacokinetics of TC20160506 (Note that TC20160506 is a de-identified name for the drug.) — TC20160506","text":"","code":"TC20160506_conc  TC20160506_dose  TC20160506_demog"},{"path":"https://billdenney.github.io/PKdata/reference/TC20160506.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Pharmacokinetics of TC20160506 (Note that TC20160506 is a de-identified name for the drug.) — TC20160506","text":"TC20160506_conc concentration-time data.  data.frame   following variables: ID Subject identifier ANALYTE Analyte measured TIME Time since first dose DAY 1 (hours) TIMEU Units time, \"hours\" CONC Plasma concentration TC20160506 (ug/L) CONCU Units plasma concentration TC20160506, \"ug/L\" TC20160506_dose dosing data TC20160506.  data.frame   following variables: ID Subject identifier ANALYTE Analyte dosed (drug name) TIME Time since first dose DAY 1 (    hours) TIMEU Units time, \"hours\" DOSE Dose TC20160506 (ug).  Note     may one dose record per subject. DOSEU Units dose, \"ug\" ROUTE Route administration TC20160506_demog demographic data TC20160506   pharmacokinetics.  data.frame following variables: ID Subject identifier AGE Subject's age (years) AGEU Units age, \"years\" SEX Subject's sex (Male/Female) WEIGHT Subject's body weight (kg) WEIGHTU Units body weight, \"kg\" object class data.frame 1494 rows 6 columns. object class data.frame 209 rows 7 columns. object class data.frame 42 rows 6 columns.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/fluorouracil.html","id":null,"dir":"Reference","previous_headings":"","what":"Pharmacokinetics of fluorouracil — fluorouracil","title":"Pharmacokinetics of fluorouracil — fluorouracil","text":"Observed data set concentration-time data fluorouracil.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/fluorouracil.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Pharmacokinetics of fluorouracil — fluorouracil","text":"","code":"fluorouracil_conc  fluorouracil_dose  fluorouracil_demog"},{"path":"https://billdenney.github.io/PKdata/reference/fluorouracil.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Pharmacokinetics of fluorouracil — fluorouracil","text":"fluorouracil_conc data frame describing concentration time following variables: ID Subject identifier TIME Time (minutes) TIMEU Units time, \"minutes\" NDOSE Nominal dose (mg/kg) NDOSEU Units nominal dose, \"mg/kg\" CONC Plasma concentration fluorouracil (ug/mL) CONCU Units plasma concentration fluorouracil, \"ug/mL\" fluorouracil_dose data frame describing dosing following variables: ID Subject identifier NDOSE Nominal dose (mg/kg) NDOSEU Units nominal dose, \"mg/kg\" TIME Time start dose (minutes) TIME_END Time end dose (minutes) TIMEU Units time, \"minutes\" ROUTE Route administration, \"intravenous bolus\" object class data.frame 48 rows 7 columns. object class data.frame 8 rows 7 columns. object class data.frame 8 rows 17 columns.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/fluorouracil.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Pharmacokinetics of fluorouracil — fluorouracil","text":"MacMillan, William E., William H. Wolberg, Peter G. Welling. 1978. \"Pharmacokinetics Fluorouracil Humans.\" Cancer Research 38 (10): 3479-82.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/hydrocortisone.html","id":null,"dir":"Reference","previous_headings":"","what":"Pharmacokinetics of hydrocortisone — hydrocortisone","title":"Pharmacokinetics of hydrocortisone — hydrocortisone","text":"Simulated data set concentration-time data hydrocortisone.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/hydrocortisone.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Pharmacokinetics of hydrocortisone — hydrocortisone","text":"","code":"hydrocortisone_sim_dose  hydrocortisone_sim_conc"},{"path":"https://billdenney.github.io/PKdata/reference/hydrocortisone.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Pharmacokinetics of hydrocortisone — hydrocortisone","text":"hydrocortisone_sim_conc data frame descrbing   concentration-time following variables: ID Subject identifier TIME Time (hours) CONC Plasma concentration hydrocortisone (ng/mL) CONCU Units plasma concentration hydrocortisone, \"ng/mL\" hydrocortisone_sim_dose data frame describing dosing   following variables: ID Subject identifier TIME Time (hours) TIMEU Units time, \"hours\" DOSE Dose hydrocortisone (mg) DOSEU Units dose hydrocortisone, \"mg\" ROUTE Route administration object class data.frame 20 rows 6 columns. object class data.frame 280 rows 5 columns.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/hydrocortisone.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Pharmacokinetics of hydrocortisone — hydrocortisone","text":"Derendorf H, Mollmann H, Barth J, Mollmann C, Tunn S, Krieg M. Pharmacokinetics oral bioavailability hydrocortisone. J Clin Pharmacol. 1991;31(5):473-6.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_conc.html","id":null,"dir":"Reference","previous_headings":"","what":"Pharmacokinetics of racemic and r-lipoic acid — lipoic_acid_conc","title":"Pharmacokinetics of racemic and r-lipoic acid — lipoic_acid_conc","text":"Data set concentration-time data racemic r-lipoic acid.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_conc.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Pharmacokinetics of racemic and r-lipoic acid — lipoic_acid_conc","text":"","code":"lipoic_acid_conc"},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_conc.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Pharmacokinetics of racemic and r-lipoic acid — lipoic_acid_conc","text":"data frame four variables: ID Subject identifier TIME Time (minutes) CONC Plasma concentration analyte (ng/mL) ANALYTE name analyte measured concentration column Period period number","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_conc.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Pharmacokinetics of racemic and r-lipoic acid — lipoic_acid_conc","text":"https://ir.library.oregonstate.edu/xmlui/bitstream/handle/1957/39168/KarnprachaChanida2013.pdf?sequence=1","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_conc.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Pharmacokinetics of racemic and r-lipoic acid — lipoic_acid_conc","text":"Karnpracha, Chanida. (2013) Comparison Pharmacokinetic Data Analysis Two Competing Pharmacokinetic Software Program. (Master's Thesis)","code":""},{"path":[]},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_demog.html","id":null,"dir":"Reference","previous_headings":"","what":"Demographics for subjects dosed with r-lipoic acid — lipoic_acid_demog","title":"Demographics for subjects dosed with r-lipoic acid — lipoic_acid_demog","text":"Demographics subjects dosed r-lipoic acid","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_demog.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Demographics for subjects dosed with r-lipoic acid — lipoic_acid_demog","text":"","code":"lipoic_acid_demog"},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_demog.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Demographics for subjects dosed with r-lipoic acid — lipoic_acid_demog","text":"data frame two variables: ID Subject identifier Sex subject's sex (F=female, M=male) Age subject's age category","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_demog.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Demographics for subjects dosed with r-lipoic acid — lipoic_acid_demog","text":"https://ir.library.oregonstate.edu/xmlui/bitstream/handle/1957/39168/KarnprachaChanida2013.pdf?sequence=1","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_demog.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Demographics for subjects dosed with r-lipoic acid — lipoic_acid_demog","text":"Karnpracha, Chanida. (2013) Comparison Pharmacokinetic Data Analysis Two Competing Pharmacokinetic Software Program. (Master's Thesis)","code":""},{"path":[]},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_dose.html","id":null,"dir":"Reference","previous_headings":"","what":"Dosing of racemic and r-lipoic acid — lipoic_acid_dose","title":"Dosing of racemic and r-lipoic acid — lipoic_acid_dose","text":"Dosing racemic r-lipoic acid","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_dose.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Dosing of racemic and r-lipoic acid — lipoic_acid_dose","text":"","code":"lipoic_acid_dose"},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_dose.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Dosing of racemic and r-lipoic acid — lipoic_acid_dose","text":"data frame six variables: ID Subject identifier Period period number ANALYTE name analyte measured concentration column TIME Time (hours) DOSE Dose lipoic acid (mg) ROUTE Route administration","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_dose.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Dosing of racemic and r-lipoic acid — lipoic_acid_dose","text":"https://ir.library.oregonstate.edu/xmlui/bitstream/handle/1957/39168/KarnprachaChanida2013.pdf?sequence=1","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_dose.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Dosing of racemic and r-lipoic acid — lipoic_acid_dose","text":"Karnpracha, Chanida. (2013) Comparison Pharmacokinetic Data Analysis Two Competing Pharmacokinetic Software Program. (Master's Thesis)","code":""},{"path":[]},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_nca.html","id":null,"dir":"Reference","previous_headings":"","what":"Noncompartmental analysis (NCA) parameters for racemic and r-lipoic acid as\ncalculated by Kinetica and WinNonlin. — lipoic_acid_nca","title":"Noncompartmental analysis (NCA) parameters for racemic and r-lipoic acid as\ncalculated by Kinetica and WinNonlin. — lipoic_acid_nca","text":"Noncompartmental analysis (NCA) parameters racemic r-lipoic acid calculated Kinetica WinNonlin.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_nca.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Noncompartmental analysis (NCA) parameters for racemic and r-lipoic acid as\ncalculated by Kinetica and WinNonlin. — lipoic_acid_nca","text":"","code":"lipoic_acid_nca"},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_nca.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Noncompartmental analysis (NCA) parameters for racemic and r-lipoic acid as\ncalculated by Kinetica and WinNonlin. — lipoic_acid_nca","text":"data frame five variables: ID Subject identifier ANALYTE name analyte measured Value column Parameter NCA parameter name Software Name version software used NCA calculation Value Value NCA parameter","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_nca.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Noncompartmental analysis (NCA) parameters for racemic and r-lipoic acid as\ncalculated by Kinetica and WinNonlin. — lipoic_acid_nca","text":"https://ir.library.oregonstate.edu/xmlui/bitstream/handle/1957/39168/KarnprachaChanida2013.pdf?sequence=1","code":""},{"path":"https://billdenney.github.io/PKdata/reference/lipoic_acid_nca.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Noncompartmental analysis (NCA) parameters for racemic and r-lipoic acid as\ncalculated by Kinetica and WinNonlin. — lipoic_acid_nca","text":"Karnpracha, Chanida. (2013) Comparison Pharmacokinetic Data Analysis Two Competing Pharmacokinetic Software Program. (Master's Thesis)","code":""},{"path":[]},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_conc.html","id":null,"dir":"Reference","previous_headings":"","what":"Data set of concentration-time data for xanthohumol and isoxanthohumol (a\nmetabolite of xanthohumol). — xanthohumol_conc","title":"Data set of concentration-time data for xanthohumol and isoxanthohumol (a\nmetabolite of xanthohumol). — xanthohumol_conc","text":"Data set concentration-time data xanthohumol isoxanthohumol (metabolite xanthohumol).","code":""},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_conc.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Data set of concentration-time data for xanthohumol and isoxanthohumol (a\nmetabolite of xanthohumol). — xanthohumol_conc","text":"","code":"xanthohumol_conc"},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_conc.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Data set of concentration-time data for xanthohumol and isoxanthohumol (a\nmetabolite of xanthohumol). — xanthohumol_conc","text":"data frame four variables: ID Subject identifier TIME Time (hours) CONC Plasma concentration analyte (ug/L) ANALYTE name analyte measured concentration column","code":""},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_conc.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Data set of concentration-time data for xanthohumol and isoxanthohumol (a\nmetabolite of xanthohumol). — xanthohumol_conc","text":"https://ir.library.oregonstate.edu/xmlui/bitstream/handle/1957/39168/KarnprachaChanida2013.pdf?sequence=1","code":""},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_conc.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Data set of concentration-time data for xanthohumol and isoxanthohumol (a\nmetabolite of xanthohumol). — xanthohumol_conc","text":"Karnpracha, Chanida. (2013) Comparison Pharmacokinetic Data Analysis Two Competing Pharmacokinetic Software Program. (Master's Thesis)","code":""},{"path":[]},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_demog.html","id":null,"dir":"Reference","previous_headings":"","what":"Demographics for subjects dosed with xanthohumol — xanthohumol_demog","title":"Demographics for subjects dosed with xanthohumol — xanthohumol_demog","text":"Demographics subjects dosed xanthohumol","code":""},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_demog.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Demographics for subjects dosed with xanthohumol — xanthohumol_demog","text":"","code":"xanthohumol_demog"},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_demog.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Demographics for subjects dosed with xanthohumol — xanthohumol_demog","text":"data frame two variables: ID Subject identifier Sex subject's sex (F=female, M=male)","code":""},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_dose.html","id":null,"dir":"Reference","previous_headings":"","what":"Dosing of xanthohumol — xanthohumol_dose","title":"Dosing of xanthohumol — xanthohumol_dose","text":"Dosing xanthohumol","code":""},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_dose.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Dosing of xanthohumol — xanthohumol_dose","text":"","code":"xanthohumol_dose"},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_dose.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Dosing of xanthohumol — xanthohumol_dose","text":"data frame four variables: ID Subject identifier TIME Time (hours) DOSE Dose xanthohumol (mg) ROUTE Route administration","code":""},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_dose.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Dosing of xanthohumol — xanthohumol_dose","text":"https://ir.library.oregonstate.edu/xmlui/bitstream/handle/1957/39168/KarnprachaChanida2013.pdf?sequence=1","code":""},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_dose.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Dosing of xanthohumol — xanthohumol_dose","text":"Karnpracha, Chanida. (2013) Comparison Pharmacokinetic Data Analysis Two Competing Pharmacokinetic Software Program. (Master's Thesis)","code":""},{"path":[]},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_nca.html","id":null,"dir":"Reference","previous_headings":"","what":"Noncompartmental analysis (NCA) parameters for xanthohumol and isoxanthohumol\nas calculated by Kinetica and WinNonlin. — xanthohumol_nca","title":"Noncompartmental analysis (NCA) parameters for xanthohumol and isoxanthohumol\nas calculated by Kinetica and WinNonlin. — xanthohumol_nca","text":"Noncompartmental analysis (NCA) parameters xanthohumol isoxanthohumol calculated Kinetica WinNonlin.","code":""},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_nca.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Noncompartmental analysis (NCA) parameters for xanthohumol and isoxanthohumol\nas calculated by Kinetica and WinNonlin. — xanthohumol_nca","text":"","code":"xanthohumol_nca"},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_nca.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Noncompartmental analysis (NCA) parameters for xanthohumol and isoxanthohumol\nas calculated by Kinetica and WinNonlin. — xanthohumol_nca","text":"data frame five variables: ID Subject identifier ANALYTE name analyte measured Value column Parameter NCA parameter name Software Name version software used NCA calculation Value Value NCA parameter","code":""},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_nca.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Noncompartmental analysis (NCA) parameters for xanthohumol and isoxanthohumol\nas calculated by Kinetica and WinNonlin. — xanthohumol_nca","text":"https://ir.library.oregonstate.edu/xmlui/bitstream/handle/1957/39168/KarnprachaChanida2013.pdf?sequence=1","code":""},{"path":"https://billdenney.github.io/PKdata/reference/xanthohumol_nca.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Noncompartmental analysis (NCA) parameters for xanthohumol and isoxanthohumol\nas calculated by Kinetica and WinNonlin. — xanthohumol_nca","text":"Karnpracha, Chanida. (2013) Comparison Pharmacokinetic Data Analysis Two Competing Pharmacokinetic Software Program. (Master's Thesis)","code":""},{"path":[]}]
